Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBOT for COVID-19 (HOT-COVID)
NCT04500626Phase 3Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Apr 2021
- Primary completion
- Aug 2022
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
A Phase 3 trial of oxygen in coronavirus disease 2019 (COVID-19), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
oxygen
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04500626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04500626.